LifeVantage raises dividend by 12.5% to $0.045 per share

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a company specializing in health and wellness products, has declared an increased quarterly cash dividend of $0.045 per share of common stock, scheduled for distribution on June 13, 2025, to shareholders on record as of May 30, 2025. This announcement represents a 12.5% hike from the previous quarter’s dividend. According to InvestingPro data, the company’s dividend has grown by 14.29% over the last twelve months, reflecting strong financial performance with a healthy gross profit margin of nearly 80%.

The dividend increase underscores LifeVantage’s commitment to delivering value to its shareholders and reflects confidence in the company’s financial stability and future prospects. The company’s strong financial position is evidenced by its solid balance sheet, with more cash than debt and a current ratio of 1.66. InvestingPro analysis suggests the stock is currently undervalued, with analysts setting price targets between $19 and $30. Despite the positive news, the company’s forward-looking statements come with a cautionary note, indicating that the payment of future dividends is not guaranteed and may vary significantly from current expectations.

LifeVantage, known for its nutrigenomics research—the study of nutrition’s impact on gene expression—offers a range of products that include the Protandim® family, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and various other wellness supplements. The company also provides a business opportunity for entrepreneurs through its network of independent consultants. With annual revenue of $212.15 million and expected sales growth this year, the company maintains impressive operational efficiency, as indicated by InvestingPro’s analysis of its financial metrics.

Established in 2003 and headquartered in Lehi, Utah, LifeVantage has positioned itself as a pioneer in the health sector with a focus on cellular health activation. The company’s product portfolio extends to pet supplements, with Petandim® designed to combat oxidative stress in dogs.

While the dividend boost is a tangible sign of LifeVantage’s current performance, supported by a return on equity of 26% and positive earnings forecasts, the company’s cautionary note to investors reflects the unpredictable nature of market conditions and the company’s performance. Potential risks and uncertainties that could affect the company’s actual results are outlined in detail in LifeVantage’s SEC filings, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. For a comprehensive analysis of LFVN’s financial health and growth prospects, investors can access detailed research reports and additional insights through InvestingPro’s extensive database of over 1,400 US stocks.

Investors are advised to consider these factors along with the announcement of the dividend increase. The information regarding the dividend and the company’s prospects is based on a press release statement from LifeVantage Corporation.

In other recent news, LifeVantage Corporation has announced the expansion of its Evolve Compensation Plan and LV360 initiatives to new markets in Asia, specifically the Philippines, Taiwan, Hong Kong, and Singapore. This expansion is set to be effective from March 1, 2025. The Evolve Compensation Plan is designed to offer LifeVantage Consultants various income opportunities, including early income bonuses and performance rewards, to support their business growth. Steve Fife, President and CEO of LifeVantage, highlighted that this initiative aligns with the company’s vision for the future of the direct sales industry. The expansion follows the successful implementation of LV360 in Canada, Mexico, and Europe earlier this year, as well as in the US, Australia, New Zealand, and Japan in 2023. LifeVantage aims to equip its consultants with essential tools to succeed in the evolving consumer and gig economy trends. The company’s growth strategy focuses on empowering independent consultants to market and sell products while offering entrepreneurial opportunities. This latest move into Asian markets is part of LifeVantage’s ongoing effort to innovate and remain competitive in the direct selling landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.